4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-076819
Options or other derivatives
- President and CEO acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
USMAN NASSIM · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-10-22 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +71,428 | $4.40 | 2025-10-22 | 71,428 | 71,428 | D |
| 2015-10-22 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +153,572 | $4.40 | 2025-10-22 | 153,572 | 153,572 | D |
Loading xslF345X03/doc4.xml…